GlaxoSmithKline LLC
GlaxoSmithKline LLC is listed as the manufacturer on 13 FDA drug label records covering 13 distinct active ingredients predominantly human prescription drug products.
About GlaxoSmithKline LLC
GlaxoSmithKline LLC is named as the labeler on 13 FDA drug label records. Its catalogue spans 13 distinct active ingredients, led by ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, BELIMUMAB, DAPRODUSTAT, DEPEMOKIMAB. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: maintenance treatment, patients aged, serevent diskus, chronic obstructive, pulmonary disease, relief acute, older limitations, vivax malaria. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 1 |
| BELIMUMAB | 1 |
| DAPRODUSTAT | 1 |
| DEPEMOKIMAB | 1 |
| FLUTICASONE FUROATE | 1 |
| FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 1 |
| MOMELOTINIB | 1 |
| NIRAPARIB | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | ORAL | 7 |
| — | — | RESPIRATORY (INHALATION) | 4 |
| — | — | SUBCUTANEOUS | 2 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from GlaxoSmithKline LLC
| Brand name | Generic | Type | Route |
|---|---|---|---|
| Anoro Ellipta | UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | HUMAN PRESCRIPTION DRUG | RESPIRATORY (INHALATION) |
| Arnuity Ellipta | FLUTICASONE FUROATE | HUMAN PRESCRIPTION DRUG | RESPIRATORY (INHALATION) |
| BENLYSTA | BELIMUMAB | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| Exdensur | DEPEMOKIMAB | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| Incruse Ellipta | UMECLIDINIUM | HUMAN PRESCRIPTION DRUG | ORAL |
| Jesduvroq | DAPRODUSTAT | HUMAN PRESCRIPTION DRUG | ORAL |
| Krintafel | TAFENOQUINE SUCCINATE | HUMAN PRESCRIPTION DRUG | ORAL |
| MALARONE | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| Ojjaara | MOMELOTINIB | HUMAN PRESCRIPTION DRUG | ORAL |
| RELENZA | ZANAMIVIR | HUMAN PRESCRIPTION DRUG | RESPIRATORY (INHALATION) |
| SEREVENT DISKUS | SALMETEROL XINAFOATE | HUMAN PRESCRIPTION DRUG | ORAL |
| Trelegy Ellipta | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | HUMAN PRESCRIPTION DRUG | RESPIRATORY (INHALATION) |
| ZEJULA | NIRAPARIB | HUMAN PRESCRIPTION DRUG | ORAL |
Frequently asked questions
How many FDA drug products does GlaxoSmithKline LLC make?
13 FDA drug label records name GlaxoSmithKline LLC as the manufacturer, covering 13 distinct active ingredients.
What active ingredients does GlaxoSmithKline LLC produce?
The most frequent active ingredients in this portfolio are ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, BELIMUMAB, DAPRODUSTAT, DEPEMOKIMAB, FLUTICASONE FUROATE.
Are GlaxoSmithKline LLC products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.